DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 01 · Volume 11 · January 1985 DOI: 10.1055/s-002-7851

  • 1
    Fareed, Jawed:

    Heparin, Its Fractions, Fragments and Derivatives Some Newer Perspectives

  • 1

    Erratum

  • 10
    Coyne, Erwin:

    From Heparin to Heparin Fractions and Derivatives

  • 13
    Hirsh, Jack; Ofosu, Fred; Buchanan, Michael:

    Rationale Behind the Development of Low Molecular Weight Heparin Derivatives

  • 17
    Walenga, Jeanine M.; Fareed, Jawed; Hoppensteadt, Debra A.:

    In Vitro Coagulant and Amidolytic Methods for Evaluating the Activity of Heparin and a Low Molecular Weight Derivative (PK 10169)

  • 26
    Barlow, Grant H.:

    The Determination of Molecular Weight Distributions on Heparin Samples

  • 29
    Losito, Ray; Losito, Carine:

    Molecular Weight of Heparin Versus Biologic Activity Some Additional Considerations

  • 34
    Mardiguian, Jean; Trillou, Michele:

    An Investigation of the Functional Role of the Carboxylic Groups of Heparin Affinity for Antithrombin III and Anti-Xa Activity of Selectively Carboxyl Esterified Heparin

  • 37
    Lasker, Sigmund E.:

    Low Molecular Weight Heparin-Like Preparations with Oral Activity

  • 40
    Walz, Daniel A.; Hung, Guo-Long:

    In Vivo Studies on the Binding of Heparin and Its Fractions with Platelet Factor 4

  • 48
    Engelberg, Hyman:

    Heparin, Heparin Fractions, and the Atherosclerotic Process

  • 56
    Fareed, Jawed; Walenga, Jeanine M.; Williamson, Karen; Emanuele, R. Martin; Kumar, Arvind; Hoppensteadt, Debra A.:

    Studies on the Antithrombotic Effects and Pharmacokinetics of Heparin Fractions and Fragments

  • 75
    Murano, Genesio; Bick, Rodger L.:

    Abstracts of Current Literature